Xynomic Pharmaceuticals Holdings, Inc. Announces Resignation of Richard Peidong Wu as Independent Director and the Chairman of the Audit Committee

On June 28, 2020, Mr. Richard Peidong Wu notified Xynomic Pharmaceuticals Holdings, Inc. of his resignation as the independent director and the chairman of the audit committee of the Company, effective June 28, 2020. Mr. Wu’s resignation was due to personal reasons and not due to any disagreement with the Company on any matter related to the operations, policies, or practices of the Company.